- Home
- HUDI vs CERO Comparison
HUDI vs CERO Comparison
Compare HUDI & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- CERO
- Stock Information
- Founded
- HUDI 1998
- CERO 2017
- Country
- HUDI China
- CERO United States
- Employees
- HUDI N/A
- CERO N/A
- Industry
- HUDI Steel/Iron Ore
- CERO
- Sector
- HUDI Industrials
- CERO
- Exchange
- HUDI Nasdaq
- CERO Nasdaq
- Market Cap
- HUDI 23.2M
- CERO 8.4M
- IPO Year
- HUDI 2021
- CERO N/A
- Fundamental
- Price
- HUDI $1.68
- CERO $0.06
- Analyst Decision
- HUDI
- CERO
- Analyst Count
- HUDI 0
- CERO 0
- Target Price
- HUDI N/A
- CERO N/A
- AVG Volume (30 Days)
- HUDI 17.1K
- CERO 38.2M
- Earning Date
- HUDI 02-03-2025
- CERO 02-20-2025
- Dividend Yield
- HUDI N/A
- CERO N/A
- EPS Growth
- HUDI N/A
- CERO N/A
- EPS
- HUDI 0.18
- CERO N/A
- Revenue
- HUDI $83,462,634.00
- CERO N/A
- Revenue This Year
- HUDI N/A
- CERO N/A
- Revenue Next Year
- HUDI N/A
- CERO N/A
- P/E Ratio
- HUDI $9.12
- CERO N/A
- Revenue Growth
- HUDI 7.65
- CERO N/A
- 52 Week Low
- HUDI $1.55
- CERO $0.05
- 52 Week High
- HUDI $4.25
- CERO $12.80
- Technical
- Relative Strength Index (RSI)
- HUDI 36.19
- CERO 38.91
- Support Level
- HUDI $1.55
- CERO $0.05
- Resistance Level
- HUDI $1.72
- CERO $0.09
- Average True Range (ATR)
- HUDI 0.10
- CERO 0.02
- MACD
- HUDI -0.01
- CERO -0.01
- Stochastic Oscillator
- HUDI 29.55
- CERO 9.62
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.